[Adverse effects of opioids, antidepressants and anticonvulsants on sex hormones : Often unnoticed but clinically relevant].

Schmerz (Berlin, Germany) Pub Date : 2022-08-01 Epub Date: 2022-07-13 DOI:10.1007/s00482-022-00655-9
Stefan Wirz, Michael Schenk, Kristin Kieselbach
{"title":"[Adverse effects of opioids, antidepressants and anticonvulsants on sex hormones : Often unnoticed but clinically relevant].","authors":"Stefan Wirz,&nbsp;Michael Schenk,&nbsp;Kristin Kieselbach","doi":"10.1007/s00482-022-00655-9","DOIUrl":null,"url":null,"abstract":"<p><p>Androgen insufficiency under treatment with opioids, antidepressants and anticonvulsants in chronic pain diseases is a side effect with a high prevalence. It can lead to clinical metabolic alterations, adynamia, stress intolerance, anemia or osteoporosis and has a significant impact on the quality of life. Opioids, antidepressants and anticonvulsants affect the hypothalamic-pituitary-gonadal axis of sex hormones. A urologist, andrologist or endocrinologist should be involved in the treatment at an early stage. The recommendation of a differential therapeutic selection of certain substances is only indicative and does not meet evidential criteria. The indications for androgen substitution must be individualized and in consideration of the risk-benefit profile. Awareness of this side effect of an otherwise lege artis medicinal pain therapy must be sharpened and compulsory included in the differential diagnostic considerations.</p>","PeriodicalId":336923,"journal":{"name":"Schmerz (Berlin, Germany)","volume":" ","pages":"293-307"},"PeriodicalIF":0.0000,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Schmerz (Berlin, Germany)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00482-022-00655-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/7/13 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Androgen insufficiency under treatment with opioids, antidepressants and anticonvulsants in chronic pain diseases is a side effect with a high prevalence. It can lead to clinical metabolic alterations, adynamia, stress intolerance, anemia or osteoporosis and has a significant impact on the quality of life. Opioids, antidepressants and anticonvulsants affect the hypothalamic-pituitary-gonadal axis of sex hormones. A urologist, andrologist or endocrinologist should be involved in the treatment at an early stage. The recommendation of a differential therapeutic selection of certain substances is only indicative and does not meet evidential criteria. The indications for androgen substitution must be individualized and in consideration of the risk-benefit profile. Awareness of this side effect of an otherwise lege artis medicinal pain therapy must be sharpened and compulsory included in the differential diagnostic considerations.

[阿片类药物、抗抑郁药和抗惊厥药对性激素的不良影响:经常被忽视,但与临床相关]。
用阿片类药物、抗抑郁药和抗惊厥药治疗慢性疼痛疾病时雄激素不足是一种发病率很高的副作用。它可导致临床代谢改变、动力不足、应激不耐受、贫血或骨质疏松症,并对生活质量产生重大影响。阿片类药物、抗抑郁药和抗惊厥药影响性激素的下丘脑-垂体-性腺轴。泌尿科医生、男科医生或内分泌科医生应该在早期参与治疗。对某些物质的差异治疗选择的建议只是指示性的,不符合证据标准。雄激素替代的适应症必须个体化,并考虑到风险-收益情况。认识到这种副作用,否则合法的药物疼痛治疗必须加强和强制包括在鉴别诊断的考虑。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信